Hear Carl June, MD, on the Giants of Gene Therapy Podcast
Yuliya Klochan, MSJ - January 17, 2023
Carl June, MD, discussed his scientific journey, from medical research officer in the U.S. Navy to leader behind the first FDA-approved gene therapy. ASGCT President Hans-Peter Kiem, MD, PhD, hosted the one-on-one conversation in the third episode of ASGCT’s Giants of Gene Therapy.
Dr. June is a professor in the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at University of Pennsylvania's Perelman School of Medicine, the director of the Center for Cellular Immunotherapy, and the director of the Parker Institute for Cancer Immunotherapy at Penn.
Dr. June has been a true pioneer in the development of CAR T cells and the use of genetically modified T cells. He was instrumental in bringing CAR T cells to the clinic and receiving the first FDA approval for gene therapy in 2017. In 2018, Dr. June was featured in TIME 100—as one of the most influential people in the world—for the invention of CAR T cell therapy for cancers like leukemia and lymphoma.
Dr. June is a prolific researcher who has published more than 500 manuscripts. He's received numerous awards and honors and has been the founder or co-founder of many companies involved in T cell therapies. His discoveries launched a new era of cancer treatment options. Dr. June has been an ASGCT member and Annual Meeting keynote speaker.
During his one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD, Dr. June spoke about his scientific career and research. The podcast features Dr. June's work on HIV, T cells, cancer, and more.
You can subscribe to the ASGCT channel wherever you listen to your podcasts (including Apple, Spotify, Overcast, Pocket Casts, and more).
Search “ASGCT” in your podcast app to subscribe to the ASGCT Podcast Network
Music by: Steven O'Brien
https://www.steven-obrien.net/
"Making Progress"
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)
In the podcast preview below, Dr. June recalled the approval of Kymriah, the first FDA-approved CAR T cell therapy for cancer. Listen to the full episode.
Listen to the full episode now
Yuliya Klochan, MSJ, is ASGCT's senior communications manager
Related Articles